Among 32,552 propensity-score-matched pairs of adults with BMI ≥35 kg/m², bariatric surgery was associated with a 52% lower incidence of dementia (HR 0.48, 95% CI: 0.39–0.58) and a 30% lower incidence of Parkinson's disease (HR 0.70, 95% CI: 0.51–0.96) compared to non-surgical controls. Surgery also reduced cardiovascular disease risk by 47%, obesity-associated cancers by 34%, and all-cause mortality by 54%, with 20-year survival of 84.7% vs 81.8% — a modest but meaningful absolute difference across a large population.
The neurodegenerative findings are arguably the most striking here. Obesity is an established risk factor for both dementia and Parkinson's, likely through overlapping pathways: chronic neuroinflammation, insulin resistance impairing cerebral glucose metabolism, and adipokine dysregulation. Bariatric surgery's dramatic metabolic reset — including near-complete type 2 diabetes remission and sustained weight loss — plausibly interrupts these mechanisms, though causal inference from observational data remains inherently limited.
Key caveats: median follow-up was only 4.7–5.9 years, short for neurodegenerative outcomes that unfold over decades. The TriNetX network skews toward healthcare-engaged patients, and individuals motivated enough to pursue surgery likely differ in unmeasured health behaviours. Propensity matching helps but cannot eliminate all confounding. Still, with 65,000 matched participants and consistent directional benefit across five distinct outcomes, this is not a marginal finding — it substantially strengthens the case for framing bariatric surgery as a systemic neuroprotective intervention, not merely a weight-loss procedure.